Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03626766 · ClinicalTrials.gov registry record · NA
Evaluating the Impact of Patient Photographs for Preventing Wrong-Patient Errors
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 10,426
- Enrollment target
NCT03626766: Completed NA study, sponsored by Columbia University.
NCT03626766 is a NA study that has completed, run by Columbia University. The registered enrollment target is 10,426 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (643% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03626766, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10,426 participants
- Enrollment target
Study Summary
This is a multi-site, 4-arm randomized controlled trial to test the effectiveness of patient photographs displayed in electronic health record (EHR) systems to prevent wrong-patient order errors. The study will be conducted at several academic medical centers that utilize two different EHR systems. Because EHR systems have different functionality for displaying patient photographs, two different study designs will be employed. In Allscripts EHR, a 2-arm randomized trial will be conducted in which providers are randomized to view order verification alerts with versus without patient photographs when placing electronic orders. In Epic EHR, a 2x2 factorial trial will be conducted in which providers are randomized to one of four conditions: 1) no photograph; 2) photograph displayed in the banner only; 3) photograph displayed in a verification alert only; or 4) photograph displayed in the banner and verification alert. The main hypothesis of this study is that displaying patient photographs in the EHR will significantly reduce the frequency of wrong-patient order errors, providing health systems with the evidence needed to adopt this safety practice.
Primary Outcome
Using the Wrong-Patient (WP) Retract-and-Reorder measure, the outcome was WP order sessions, defined as series of orders placed by 1 clinician for 1 patient that included ≥1 WP order. The Wrong-Patient Retract-and-Reorder (RAR) measure is an automated, validated, and reliable measure endorsed by the National Quality Forum (NQF #2723). The RAR measure identifies orders placed for a patient that are retracted within 10 minutes, and then placed by the same provider for a different patient within th
Interventions
- BEHAVIORAL Photo in Verification Alert
- BEHAVIORAL Photo in Banner
- BEHAVIORAL Photo in Banner and Verification Alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,426 participants |
| Start Date | 2021-11-16 |
| Est. Completion | 2024-04-01 |
| Phase | NA |
What the finished NCT03626766 record still lists
NCT03626766 is an interventional study that assigns participants to a tested intervention. Its 10,426 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (643% higher).
The record links to 0 conditions, and to 3 interventions - of which Photo in Verification Alert is the first listed.
NCT03626766 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03626766 about?
NCT03626766 is a clinical study titled "Evaluating the Impact of Patient Photographs for Preventing Wrong-Patient Errors". This is a multi-site, 4-arm randomized controlled trial to test the effectiveness of patient photographs displayed in electronic health record (EHR) systems to prevent wrong-patient order errors. The study will be conducted at several academic medical centers that utilize two different EHR systems. ...
What is the current status of trial NCT03626766?
This trial is currently completed. It is a NA study. The enrollment target is 10,426 participants. The study started on 2021-11-16. Estimated completion is 2024-04-01.
What interventions are being tested in trial NCT03626766?
The interventions under investigation include: Photo in Verification Alert (BEHAVIORAL), Photo in Banner (BEHAVIORAL), Photo in Banner and Verification Alert (BEHAVIORAL).
Who is sponsoring clinical trial NCT03626766?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03626766's enrollment target sits among peer trials
10,426 14th of 2000 higher than 1,987 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07157774 · 10,450 participants · Phase 3
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- NCT05759299 · 10,500 participants
International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia
- NCT06891222 · 10,500 participants
A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening
- NCT06081517 · 10,600 participants
Evaluating Disparities in Precision Oncology
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI